The pressures of the pandemic have brought into sharp focus the need for greater innovation and modernisation across the pharmaceutical industry. This is especially the case when it comes to traditional clinical trials, which have often been marred by costly, inefficient and logistically demanding processes. But things are changing and new technologies are making decentralised trials increasingly possible. Carolina Rossi Wosiack, Managing Director of EMEA at digital consultancy CI&T, explores the benefits these new technologies and processes will have on the industry.